Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial CarcinomaThomas Powles, Petros Grivas, Wim Demey et al.|New England Journal of Medicine|2020Cited by 1.5k
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-UpThomas Powles, Petros Grivas, Se Hoon Park et al.|Journal of Clinical Oncology|2023Cited by 210
A systematic evaluation of nucleotide properties for CRISPR sgRNA designPei Fen Kuan, Bo Huang, Scott Powers et al.|BMC Bioinformatics|2017Cited by 38
First-in-human study of lisaftoclax (APG-2575), a novel BCL-2 inhibitor (BCL-2i), in patients (pts) with relapsed/refractory (R/R) CLL and other hematologic malignancies (HMs).Sikander Ailawadhi, Yifan Zhai, Asher Chanan‐Khan et al.|Journal of Clinical Oncology|2021Cited by 25